Annual Current Assets
$96.37 M
-$76.62 M-44.29%
December 31, 2022
Summary
- As of March 9, 2025, SRNE annual total current assets is $96.37 million, with the most recent change of -$76.62 million (-44.29%) on December 31, 2022.
- During the last 3 years, SRNE annual current assets has risen by +$28.79 million (+42.59%).
- SRNE annual current assets is now -46.33% below its all-time high of $179.56 million, reached on December 31, 2018.
Performance
SRNE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$133.11 M
+$32.35 M+32.11%
June 30, 2023
Summary
- As of March 9, 2025, SRNE quarterly total current assets is $133.11 million, with the most recent change of +$32.35 million (+32.11%) on June 30, 2023.
- Over the past year, SRNE quarterly current assets has increased by +$32.35 million (+32.11%).
- SRNE quarterly current assets is now -59.80% below its all-time high of $331.12 million, reached on March 31, 2022.
Performance
SRNE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
SRNE Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.3% | +32.1% |
| 3 y3 years | +42.6% | +32.1% |
| 5 y5 years | +224.5% | +32.1% |
SRNE Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.3% | at low | -59.8% | +38.1% |
| 5 y | 5-year | -44.3% | +42.6% | -59.8% | +168.2% |
| alltime | all time | -46.3% | -100.0% | -59.8% | -100.0% |
Sorrento Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $133.11 M(+32.1%) |
| Mar 2023 | - | $100.76 M(+4.6%) |
| Dec 2022 | $376.47 M(-27.9%) | $96.37 M(-45.5%) |
| Sep 2022 | - | $176.96 M(-9.7%) |
| Jun 2022 | - | $196.05 M(-40.8%) |
| Mar 2022 | - | $331.12 M(+91.4%) |
| Dec 2021 | $521.83 M(+16.1%) | $172.99 M(-13.8%) |
| Sep 2021 | - | $200.72 M(+29.3%) |
| Jun 2021 | - | $155.26 M(-41.6%) |
| Mar 2021 | - | $265.70 M(+208.1%) |
| Dec 2020 | $449.59 M(-8.3%) | $86.23 M(-18.6%) |
| Sep 2020 | - | $105.99 M(+92.7%) |
| Jun 2020 | - | $55.00 M(+10.8%) |
| Mar 2020 | - | $49.63 M(-26.6%) |
| Dec 2019 | $490.04 M(+10.2%) | $67.59 M(+0.0%) |
| Sep 2019 | - | $67.57 M(-27.7%) |
| Jun 2019 | - | $93.51 M(-21.1%) |
| Mar 2019 | - | $118.58 M(-34.0%) |
| Dec 2018 | $444.52 M(+10.6%) | $179.56 M(+23.6%) |
| Sep 2018 | - | $145.25 M(+165.3%) |
| Jun 2018 | - | $54.75 M(+49.7%) |
| Mar 2018 | - | $36.57 M(+23.1%) |
| Dec 2017 | $401.91 M(+28.8%) | $29.70 M(-33.6%) |
| Sep 2017 | - | $44.71 M(-26.2%) |
| Jun 2017 | - | $60.59 M(+44.0%) |
| Mar 2017 | - | $42.09 M(-53.0%) |
| Dec 2016 | $311.93 M(+54.0%) | $89.65 M(+24.8%) |
| Sep 2016 | - | $71.84 M(-50.9%) |
| Jun 2016 | - | $146.26 M(+103.9%) |
| Mar 2016 | - | $71.73 M(-49.1%) |
| Dec 2015 | $202.50 M(+199.4%) | $141.02 M(+13.0%) |
| Sep 2015 | - | $124.81 M(+132.0%) |
| Jun 2015 | - | $53.81 M(-13.4%) |
| Mar 2015 | - | $62.16 M(-15.9%) |
| Dec 2014 | $67.63 M(+12.8%) | $73.92 M(+61.2%) |
| Sep 2014 | - | $45.84 M(-10.9%) |
| Jun 2014 | - | $51.44 M(+64.7%) |
| Mar 2014 | - | $31.23 M(-4.3%) |
| Dec 2013 | $59.95 M | $32.63 M(+374.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $6.87 M(+16.1%) |
| Jun 2013 | - | $5.92 M(-43.4%) |
| Mar 2013 | - | $10.46 M(+99.2%) |
| Dec 2012 | $1.53 M(+51.3%) | $5.25 M(-20.4%) |
| Sep 2012 | - | $6.60 M(-14.6%) |
| Jun 2012 | - | $7.73 M(+204.4%) |
| Mar 2012 | - | $2.54 M(-28.6%) |
| Dec 2011 | $1.01 M(+652.9%) | $3.56 M(+51.8%) |
| Sep 2011 | - | $2.34 M(-22.1%) |
| Jun 2011 | - | $3.01 M(-36.5%) |
| Mar 2011 | - | $4.74 M(-14.7%) |
| Dec 2010 | $134.30 K(+39.9%) | $5.55 M(+171.7%) |
| Sep 2010 | - | $2.04 M(-8.8%) |
| Jun 2010 | - | $2.24 M(-17.2%) |
| Mar 2010 | - | $2.71 M(-21.7%) |
| Dec 2009 | $96.00 K(>+9900.0%) | $3.46 M(-13.5%) |
| Sep 2009 | - | $4.00 M(+1268.2%) |
| Jun 2009 | - | $292.20 K(-21.4%) |
| Mar 2009 | - | $371.80 K(>+9900.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2008 | - | $437.50 K(>+9900.0%) |
| Jun 2008 | - | $0.00(-100.0%) |
| Mar 2008 | - | $17.10 K(-21.9%) |
| Dec 2007 | $0.00 | $21.90 K(-27.0%) |
| Sep 2007 | - | $30.00 K(-43.6%) |
| Jun 2007 | - | $53.20 K(-38.1%) |
| Mar 2007 | - | $85.90 K(>+9900.0%) |
| Dec 2006 | - | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | - | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sep 2004 | - | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00 |
FAQ
- What is Sorrento Therapeutics annual total current assets?
- What is the all time high annual current assets for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual current assets year-on-year change?
- What is Sorrento Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly current assets year-on-year change?
What is Sorrento Therapeutics annual total current assets?
The current annual current assets of SRNE is $96.37 M
What is the all time high annual current assets for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual total current assets is $179.56 M
What is Sorrento Therapeutics annual current assets year-on-year change?
Over the past year, SRNE annual total current assets has changed by -$76.62 M (-44.29%)
What is Sorrento Therapeutics quarterly total current assets?
The current quarterly current assets of SRNE is $133.11 M
What is the all time high quarterly current assets for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly total current assets is $331.12 M
What is Sorrento Therapeutics quarterly current assets year-on-year change?
Over the past year, SRNE quarterly total current assets has changed by +$32.35 M (+32.11%)